The Selangor Life Sciences Convention Synergy Conference (SLiSS) 2024 will be held on 17 and 18 October 2024 at KLCC, Kuala Lumpur.
This two day event was formerly known as the Selangor International Healthcare Conference.
The Conference will focus on:
PRECISION HEALTH on Day 1: This field of medicine tailors individual treatment plans to a persons specific genes, environment, and lifestyle.
GENERATIVE AI & HEALTHCARE on Day 2: Artificial Intelligence (AI) and its potential to transform healthcare. This involves using artificial intelligence to develop new drugs, diagnostics, treatments and patient communication.
The Selangor Life Sciences Convention Synergy Conference (SLiSS) 2024 offers a unique platform to explore the latest advancements in healthcare, particularly for those keen on staying updated.
The conference will provide delegates with the following enriching opportunities:
Being at the Forefront: These two related main topics are at the cutting edge of medical research and application. Precision Health is rapidly shifting its approach to healthcare towards a more personalized and effective person-centric approach at the cellular level.
AI is a rapidly evolving area with immense potential to reshape healthcare delivery and treatment. Attending this session allows you to stay ahead of the curve and understand how AI might impact your field.
By attending the Selangor Life Sciences Convention Synergy Conference (SLiSS) 2024, youll gain exposure to real-world applications of Generative AI in healthcare and the latest advancements in Precision Health. This knowledge, especially in the context of preventive care and wellness programs, can significantly enhance patient outcomes.
At the conference, youll have the unique opportunity to gain insights in the field of Precision Health and Generative AI. This invaluable experience will help shape your understanding and future application of these technologies.
Networking Opportunities: Attending conferences allows you to connect with other professionals interested in AI and healthcare. This can lead to valuable collaborations, knowledge sharing, and staying updated on the latest developments in the field.
Speakers and Topics:
•Prof. Dr. Roberto Grobman, Chairman, Chief Scientist & Orthogeneticist, USA – Cell Metabolism: Overview of metabolic pathways, energy flow in a cell, and anabolism and catabolism.
• Dr. J.S. Rajkumar, Surgical Gastroenterologist, Founder & Chairman of Lifeline Hospitals, India – Defining Tomorrow’s Medicine. Personalization in medicine—driven by data-powered insights.
• Dr. Le Lu, Head of Alibaba DAMO Academy’s Global Medical AI R&D Team – Tech to the Future. Dedicating pioneering cutting-edge scientific and technological research to shape the future to diagnose and create personalized treatment plans.
• Dr. Madan Mohan, Senior Interventional Cardiologist, MGM Healthcare, Chennai, India – The Future of Healthcare: Molecular Basis of Health and Disease. How genetic testing saves lives in heart.
• Ms. Shivani Narasimhan, Research Scientist (Genomics and Bioinformatics), Precisya Southeast Asia Pvt Ltd. – The Future of Healthcare: Molecular Basis of Health and Disease. Epigenetic and molecular changes for the onset and progression of diseases.
• Novartis—The Promise of Pharmacogenetics. Personalized Prescription—Genetic information, in combination with other factors, offers much better-targeted results in prescribing.
• Radhakrishnan S, Executive Director Transceptar – The tremendous growth opportunities in Precision Health.
• Prof. Dr. Chong Pei Pei, Professor at the Faculty of Health & Medical Sciences, Taylor’s University – AI in Healthcare Today and Beyond.
And many more Speakers and Topics that are transforming the healthcare of tomorrow.
Registration is OPEN.
For more information and to register visit – https://infomedconference.com/
This conference is HRDF Claimable. To Claim from HRDF (if your organization contributes to HRDF)
Please contact WhatsApp at +6012-6369 438 or email us at bart.eduguidemsia@gmail.com.
Source — https://infomed.com.my/








Leave a Reply